Suven Pharmaceuticals Q1 Results

  • BSE: 543064
  • NSE: SUVENPHAR
  • ISIN: INE03QK01018
  • Sector: Biotechnology & Drugs
BSE
631.1-15.90 (-2.46%)
Volume2.26 K
Updated: Thu 30 May, 2024 | 15:28:46
NSE
632.05-18.50 (-2.84%)
Volume72.15 K
Updated: Thu 30 May, 2024 | 15:32:24
Today: 629.75
654.15
52-Wk: 427.05
767.00

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Pharmaceuticals Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 23Mar 23QoQ Comp
    Total Revenue 347.55369.36-5.90%
    Selling/ General/ Admin Expenses Total 28.7425.6012.27%
    Depreciation/ Amortization 12.5411.964.87%
    Other Operating Expenses Total 16.2115.772.78%
    Total Operating Expense 193.13212.24-9.00%
    Operating Income 154.42157.12-1.72%
    Net Income Before Taxes 163.94166.21-1.36%
    Net Income 120.59123.97-2.73%
    Diluted Normalized EPS 4.744.87-2.58%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App